Also in this section

• Projects
• G-FINDER: Global Funding of Innovation for Neglected Diseases
• The Effectiveness of Financing and Aid Coordination in Responding to the HIV Epidemic in the Pacific Region
• African Regulatory Systems Research
• Health Innovation Systems in Africa
• The malaria product pipeline: planning for the future (2007)
• Unleashing Europe's biopharmaceutical innovation potential: An application to AIDS vaccine R&D (2008)
• Health Economics Projects

G-FINDER: Global Funding of Innovation for Neglected Diseases

The G-FINDER survey tracks global investment on an annual basis into research and development (R&D) of new medicines for neglected diseases. The first G-FINDER report, published in February 2009, shed light on 2007 global investments and provided comprehensive, consistent and comparable data across all diseases for the first time. The Health Policy Division published results from the second survey on 15 December 2009, which provides information on global investments for 2008 as well as examining changes against the 2007 baseline and identifying early trends and patterns in light of the recent global financial crisis. (Click here to view the full report, and here to see read about the launch)

The G-FINDER survey collects public, private and philanthropic investment data on all aspects of developing new medicines for neglected diseases, from basic research, through discovery and development, to the post-registration activities needed to support large-scale use. (Click here to see the full list of participants in G-FINDER 2009)

A wide range of neglected diseases are covered by the survey, ranging from diseases like malaria, sleeping sickness and TB, to developing-country strains of global diseases such as pneumonia, meningitis and HIV/AIDS.

The survey also covers a broad range of neglected disease products, from new drugs, diagnostics, vaccines and microbicides, to insecticides and other pharmaceuticals.

Previous neglected disease surveys have not been funded to deliver the broad scope and depth of detail of the G-FINDER survey, or have been one-off efforts. This survey is funded to be repeated each year until 2012 and ideally beyond.

Taken together, these features allow the G-FINDER survey to provide invaluable evidence to policy-makers and funders to inform and support the major decisions being made in global health funding now and into the future.

The survey is funded by the Bill & Melinda Gates Foundation.

"Building on recent successes in global health will require new tools to diagnose, treat, and prevent neglected tropical diseases. The G-FINDER survey is a call to action to donors worldwide to support greater R&D for infectious diseases."
- Regina Rabinovich, Director, Infectious Diseases Development of the Bill & Melinda Gates Foundation

G-FINDER Newsletter April 2009

G-FINDER Newsletter June 2008